BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7439880)

  • 21. Increased blood proinsulin and decreased C-peptide levels in patients with pancreatic cancer.
    Nakamori S; Ishikawa O; Ohigashi H; Sasakuma F; Shimizu T; Nakaizumi A; Furukawa H; Sasaki Y; Imaoka S
    Hepatogastroenterology; 1999; 46(25):16-24. PubMed ID: 10228759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excess glycaemic excursions after an oral glucose tolerance test compared with a mixed meal challenge and self-measured home glucose profiles: is the OGTT a valid predictor of postprandial hyperglycaemia and vice versa?
    Meier JJ; Baller B; Menge BA; Gallwitz B; Schmidt WE; Nauck MA
    Diabetes Obes Metab; 2009 Mar; 11(3):213-22. PubMed ID: 18564177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ontogeny of neurotensin in the fetal sheep.
    Read D; Shulkes A
    J Dev Physiol; 1991 Sep; 16(3):155-62. PubMed ID: 1797922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone resorption is decreased postprandially by intestinal factors and glucagon-like peptide-2 is a possible candidate.
    Holst JJ; Hartmann B; Gottschalck IB; Jeppesen PB; Miholic J; Henriksen DB
    Scand J Gastroenterol; 2007 Jul; 42(7):814-20. PubMed ID: 17558904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevation of plasma glucagon-like immunoreactivity (GLI) in patients with liver cirrhosis.
    Watanabe A; Hashimoto M; Higashi T; Kobayashi M; Nakatsukasa H; Yamauchi Y; Watanabe M; Fujiwara M; Nagashima H
    J Med; 1986; 17(2):95-108. PubMed ID: 3473162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of truncal vagotomy on neurotensin-like immunoreactivity release in dogs.
    Yoshiya K; Kishimoto T; Kusuhara K; Ishikawa Y; Utsunomiya J
    Gastroenterol Jpn; 1985 Jun; 20(3):197-200. PubMed ID: 4043655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotensin in the rat parabrachial region: ultrastructural localization and extrinsic sources of immunoreactivity.
    Milner TA; Pickel VM
    J Comp Neurol; 1986 May; 247(3):326-43. PubMed ID: 3522659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release of neurotensin-like immunoreactivity (NTLI) from rat intestine following administration of bombesin.
    Rökaeus A; McDonald T
    Acta Physiol Scand; 1980 Nov; 110(3):326. PubMed ID: 7211416
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of endogenous somatostatin in postprandial hypersecretion of neurotensin in patients after gastrectomy.
    Sakamoto T; Miyata M; Izukura M; Tanaka Y; Iwase K; Imabun S; Matsuda H
    Ann Surg; 1997 Apr; 225(4):377-81. PubMed ID: 9114796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevation of plasma neurotensin during lipid perfusion of rat small intestine.
    Ferris CF; Hammer RA; Leeman SE
    Peptides; 1981; 2 Suppl 2():263-6. PubMed ID: 7343961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatic tumours produce neurotensin.
    Blackburn AM; Bryant MG; Adrian TE; Bloom SR
    J Clin Endocrinol Metab; 1981 Apr; 52(4):820-2. PubMed ID: 7204545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A radioimmunoassay for neurotensin.
    Kronheim S; Sheppard MC; Miller J
    Clin Endocrinol (Oxf); 1981 Feb; 14(2):159-64. PubMed ID: 7261413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma radioimmunoassayable neurotensin responses to the administration of various nutrients.
    Ito S; Matsubara Y; Sihibata A
    Tohoku J Exp Med; 1982 Jan; 136(1):109-10. PubMed ID: 7071824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Radioimmunoassay of plasma neurotensin and clinical application].
    Matsumura M; Ono M; Mori H; Saito S
    Horumon To Rinsho; 1983 Jun; 31(6):531-4. PubMed ID: 6883768
    [No Abstract]   [Full Text] [Related]  

  • 35. A radioimmunoassay for neurotensin in human plasma.
    Blackburn AM; Bloom SR
    J Endocrinol; 1979 Nov; 83(2):175-81. PubMed ID: 574894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma neurotensin: lack of a differentiation and tumor marker in children with neuroblastoma.
    Becker K; Berthold F
    Pediatr Hematol Oncol; 1992; 9(3):269-72. PubMed ID: 1525006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurotensins and their therapeutic potential: research field study.
    Kan Yeung AW; Georgieva MG; Kirilov K; Balacheva AA; Peeva MI; Horbańczuk OK; Horbańczuk JO; Lucarini M; Durazzo A; Santini A; Souto EB; Pajpanova TI; Milella L; Atanasov AG; Tzvetkov NT
    Future Med Chem; 2020 Oct; 12(19):1779-1803. PubMed ID: 33032465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Humoral aspects of dumping syndrome.
    Blackburn AM; Bloom SR
    Lancet; 1981 Jan; 1(8211):92-3. PubMed ID: 6109136
    [No Abstract]   [Full Text] [Related]  

  • 39. [Neurotensin].
    Satoh K; Shimosegawa T
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():269-72. PubMed ID: 20960781
    [No Abstract]   [Full Text] [Related]  

  • 40. [Neurotensin].
    Shimosegawa T; Toyota T
    Nihon Rinsho; 1999 Dec; 57 Suppl():74-7. PubMed ID: 10778067
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.